PerkinElmer Inc. is regarded as the most reputed and leading organizations in the whole world. It is providing its services for the health improvement, people safety and environment. ViaCord is a branch of the company that deals in the collection of cord cells for the family. Few days back the company announced that ViaCord is soon going to provide the service of umbilical cord blood banking for the easy exctraction of the stem cells. Baby umbilical cord is known to contain rich quantity of Mesenchymal stem cells. The storage of stem cells of the cord tissue and cord blood stem cells of the newly born provides a wide range of cells.
These cells then increase the chances of successful treatment for a number of diseases. There have been performed about more than fifty clinical trials for these mesenchymal stem cells and the results have been published. The findings highlight the effectiveness of these umbilical cord stem cells for the medical and science field. The research that was published shows that the stem cells obtained from tissue are capable to cure a number of diseases that is cardio, diabetes type 1, Alzheimer’s diseases, injuries or Parkinson’s disease.
These services provided are the first that have been enabled after an agreement with Auxocell Laboratories, Inc. It is the top stem cell therapeutic and also regenerative company of medicine. As per the terms of license contract, the customers of the ViaCord will be provided with full access of banking of cord tissue for the whole family. It is being done for the expansion of mesenchymal stem cells extracted from the tissues present in umbilical cord. Moreover, ViaCord is also making use of the Auxocell’s technology that is fully validated for the processing and cryopreservation of these cells.
ViaCord’s chief scientific officer, Morey Kraus said that in the meeting of International Placenta Stem Cell Society in October 2010, Auxocell researchers presented their findings. They suggested that stem cells obtained from the umbilical cord blood collection when mixed with the cord blood stem cells help in engraftment that is six times much improved simply over the cord blood. ViaCord is further very interested in providing other stem cell sources for its customers. The collaboration between both the organizations is so strong that it has invoked further high confidence in the customers to use the services of the company.
All this is just because of valid techniques of stem cell processing and special access for the expansion of stem cells. Thus the ViaCord cord blood banking for the family is currently providing expectant families with the choice of cord blood preservation of their baby to be used by the child or family member in future. Till date, the company has successfully provided the storage service for more than 250,000 infants. Twenty years ago there was only one disease for which these stem cells were used and that is Fanconi’s anemia. Nowadays, there are around eighty wide ranges of diseases that can be successfully cured. These include cancer, immune disorder and also various blood disorders. In 2010 the company was found to generate an income of about 1.7 billion with employees up to 6200 and serving above 150 countries.
It is true that Cord Blood America, Inc. is soon going to provide the umbilical cord blood banking facility and that too at a discounted rate for the members. It has been possible because of the recent agreement between Cord Blood America and BlueCross BlueShield of Tennessee. The price charged would be much lower as compared to BlueCross BlueShield contacts signed earlier. The total number of conscription for the BlueCross is three million. Out of them more than fifty percent are situated in Tennessee. Members however can also enlist in the ‘Afford-A-Cord’ program of the Cord Blood America. Under this program members can go for storage process in the beginning at very low initial charges.
Célle's revolutionary service provides women with the unique opportunity to collect and preserve vital stem cells. 
